Chinese and Western vaccines compared
Big changes, all of a sudden
Live with the virus
Vice-premier, Sun Chunlan
China entering a new situation
Virus ability to cause disease weakening
Lifting most severe Covid policies
End of quarantine camps
People can isolate at home
No more family separations
Close contacts not taken to camps
Strict ban on blocking fire exits
No need to show tests for venues
Less rules on internal travel
Lateral flow tests to replace PCR tests in most areas
Lockdowns continue in smaller more targeted areas
Foreign travel soon
Cases, 30,000 +
Everyone will be exposed
Will the medical system will be overwhelmed?
National Health Commission
All localities, focus on improving the vaccination rate of people aged 60-79,
accelerating the vaccination rate of people aged 80 and above,
and making special arrangements
Prof Ivan Hung, Hong Kong University
The main way for China to exit Covid with the least damage is via vaccination and three doses of vaccination is a must
Hopefully before Chinese New Year (January 22) Rabbit
Strategic Advisory Group of Experts on Immunization (SAGE)
The vaccine is safe and effective for all individuals aged 18 and above.
Individuals may choose to delay vaccination for 3 months following the infection.
An inactivated vaccine with adjuvant
(that is routinely used in many other vaccines)
with a documented good safety profile, including in pregnant women.
Symptomatic SARS-CoV-2 infection and efficacy against hospitalization 79%
Does it prevent infection and transmission?
No substantive data
Does it work against new variants of SARS-
SAGE currently recommends using this vaccine
Not yet been evaluated in the context of circulation of widespread variants of concern.
How does this vaccine compare to other vaccines already in use?
We cannot compare the vaccines head-to-head,
(different approaches taken in designing the respective studies)
but overall, all of the vaccines that have achieved WHO Emergency Use Listing,
are highly effective in preventing severe disease and hospitalization due to COVID-19.
Comparison with Western vaccines
Pfizer original paper
BNT162b2 was 95% effective in preventing Covid-19
Later analysis from
Efficacy and effectiveness of covid-19 vaccine – absolute vs. relative risk reduction
AAR, Pfizer, during the trial period,
Absolute risk of a disease is your risk of developing the disease over a time period.
Five to six-months update, AAR
mRNA1273 (Moderna-NIH) 4.9%